SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,607,342 | +14.6% | 126,693 | +161.8% | 0.01% | +12.5% |
Q2 2023 | $2,275,815 | -1.4% | 48,401 | -12.0% | 0.01% | 0.0% |
Q1 2023 | $2,308,849 | +1.0% | 55,025 | -8.2% | 0.01% | -11.1% |
Q4 2022 | $2,285,959 | -2.6% | 59,936 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $2,347,000 | +4.0% | 59,936 | -14.2% | 0.01% | 0.0% |
Q2 2022 | $2,256,000 | -8.2% | 69,834 | -5.9% | 0.01% | +12.5% |
Q1 2022 | $2,457,000 | -15.9% | 74,242 | +8.1% | 0.01% | 0.0% |
Q4 2021 | $2,921,000 | +0.8% | 68,671 | +5.0% | 0.01% | -11.1% |
Q3 2021 | $2,898,000 | +45.6% | 65,396 | +86.6% | 0.01% | +28.6% |
Q2 2021 | $1,991,000 | -21.5% | 35,042 | +3.4% | 0.01% | -22.2% |
Q1 2021 | $2,537,000 | -17.6% | 33,895 | -4.8% | 0.01% | -18.2% |
Q4 2020 | $3,079,000 | +4.1% | 35,591 | -26.5% | 0.01% | -8.3% |
Q3 2020 | $2,959,000 | +34.9% | 48,421 | -8.2% | 0.01% | +33.3% |
Q2 2020 | $2,193,000 | +98.3% | 52,743 | +36.9% | 0.01% | +80.0% |
Q1 2020 | $1,106,000 | -60.2% | 38,523 | 0.0% | 0.01% | -50.0% |
Q4 2019 | $2,781,000 | -50.6% | 38,523 | -3.9% | 0.01% | -54.5% |
Q3 2019 | $5,626,000 | +104.9% | 40,100 | +167.3% | 0.02% | +120.0% |
Q2 2019 | $2,746,000 | +15.1% | 15,000 | 0.0% | 0.01% | +11.1% |
Q1 2019 | $2,386,000 | +398.1% | 15,000 | +200.0% | 0.01% | +350.0% |
Q4 2018 | $479,000 | -32.2% | 5,000 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $706,000 | -9.8% | 5,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $783,000 | -2.7% | 5,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $805,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |